Rosemary Tan

Dr Rosemary Tan is the Chief Executive Officer of CoV Biotechnology. She received her BSc from the University of Calgary, Canada before going to the Institute of Cell and Molecular Biology, Osaka University and the Department of Immunology at the Medical School in the University of Tokyo. She obtained her PhD from NUS.

Prior to joining CoV Biotechnology, Dr Tan founded Veredus Laboratories and successfully led the company to acquisition by Japanese conglomerate Sekisui Chemical. Under her leadership, Veredus supported key national efforts during the H1N1 and the COVID pandemic.